228 related articles for article (PubMed ID: 18706526)
1. Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
Lalvani A; Millington KA
Autoimmun Rev; 2008 Dec; 8(2):147-52. PubMed ID: 18706526
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
Sellam J; Hamdi H; Roy C; Baron G; Lemann M; Puéchal X; Breban M; Berenbaum F; Humbert M; Weldingh K; Salmon D; Ravaud P; Emilie D; Mariette X;
Ann Rheum Dis; 2007 Dec; 66(12):1610-5. PubMed ID: 17456528
[TBL] [Abstract][Full Text] [Related]
4. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
Kwakernaak AJ; Houtman PM; Weel JF; Spoorenberg JP; Jansen TL
Clin Rheumatol; 2011 Apr; 30(4):505-10. PubMed ID: 20737179
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the use of the interferon-γ response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-α therapy: a prospective head-to-head cross-sectional study.
Martyn-Simmons CL; Mee JB; Kirkham BW; Groves RW; Milburn HJ
Br J Dermatol; 2013 May; 168(5):1012-8. PubMed ID: 23278714
[TBL] [Abstract][Full Text] [Related]
6. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
7. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
Al-Taweel T; Strohl M; Pai M; Martel M; Bessissow T; Bitton A; Seidman E; Afif W
Dig Dis Sci; 2018 Oct; 63(10):2695-2702. PubMed ID: 29968143
[TBL] [Abstract][Full Text] [Related]
8. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
9. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
Tomio J; Yamana H; Matsui H; Yamashita H; Yoshiyama T; Yasunaga H
Int J Rheum Dis; 2017 Nov; 20(11):1674-1683. PubMed ID: 29076252
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders.
Smith R; Cattamanchi A; Steingart KR; Denkinger C; Dheda K; Winthrop KL; Pai M
Curr Opin Rheumatol; 2011 Jul; 23(4):377-84. PubMed ID: 21519268
[TBL] [Abstract][Full Text] [Related]
12. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
13. Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment.
Bocchino M; Matarese A; Bellofiore B; Giacomelli P; Santoro G; Balato N; Castiglione F; Scarpa R; Perna F; Signoriello G; Galati D; Ponticiello A; Sanduzzi A
Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):907-13. PubMed ID: 18470544
[TBL] [Abstract][Full Text] [Related]
14. [Update of the guidelines of the Israeli Association of Rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers].
Balbir-Gurman A; Lidgi M; Elkayam O
Harefuah; 2014 Jun; 153(6):359-61, 366. PubMed ID: 25095612
[TBL] [Abstract][Full Text] [Related]
15. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
16. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
Santos JA; Duarte R; Nunes C
Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review.
Chiappini E; Bonsignori F; Accetta G; Boddi V; Galli L; Biggeri A; De Martino M
Int J Immunopathol Pharmacol; 2012; 25(2):335-43. PubMed ID: 22697065
[TBL] [Abstract][Full Text] [Related]
19. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
